R L Bell Selected Research

R L Bell Research Topics

3	Alcoholism (Alcohol Abuse) 01/2020 - 06/2015
2	Inflammation (Inflammations) 07/2015 - 08/2000
2	Substance-Related Disorders (Drug Abuse) 06/2015 - 11/2008
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Infections 01/2022
1	Neoplasms (Cancer) 07/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2004
1	Carcinogenesis 05/2003
1	Adenoma (Adenomas) 05/2003
1	Colonic Neoplasms (Colon Cancer) 05/2003
1	Colonic Polyps 05/2003
1	Colitis 12/2002
1	Acute Disease 12/2002
1	Ulcerative Colitis 12/2002
1	Wounds and Injuries (Trauma) 04/2001
1	Pneumothorax 04/2001
1	Lung Diseases (Lung Disease) 04/2001
1	Hemothorax 04/2001
1	Anaphylaxis (Anaphylactic Shock) 08/2000

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2015
2	Ethanol (Ethyl Alcohol)IBA 01/2020 - 04/2004
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Nicotine FDA Link 01/2016
1	CytokinesIBA 07/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2015
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2015
1	LactamsIBA 06/2015
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2015
1	EnzymesIBA 05/2003
1	Matrix Metalloproteinases (MMPs)IBA 05/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2003
1	Matrix Metalloproteinase InhibitorsIBA 05/2003
1	A 177430IBA 05/2003
1	LeukotrienesIBA 08/2000